These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 13001102)

  • 1. [Antibodies against factor P with a high titer in human blood].
    GUTHOF O
    Klin Wochenschr; 1952 Aug; 30(31-32):763. PubMed ID: 13001102
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the P factor in blood stains].
    SCHNUG G
    Dtsch Z Gesamte Gerichtl Med; 1952; 41(4-5):451-3. PubMed ID: 13043447
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the blood factor P].
    LILLE SZYSZKOWICZ I; TAYTSCH Z
    Pol Tyg Lek (Wars); 1951 Jun; 6(25-26):805-9. PubMed ID: 14875562
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental studies on the properdin system of the rabbit. (IV) Relationship of properdin titer and antibody-forming activity].
    YAMAMASU N
    Nihon Saikingaku Zasshi; 1961 Dec; 16():1084-9. PubMed ID: 14008820
    [No Abstract]   [Full Text] [Related]  

  • 5. [Frequency of the capacity of furnishing an RP in the serum of blood bank donors and its relation to blood groups and Rh factor].
    GALLO E; CALLEGARO A; CALAPAJ GG
    Boll Ist Sieroter Milan; 1959; 38():364-7. PubMed ID: 13849891
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological properties of the P factor; distribution in the population of Trieste].
    BELSASSO E; VALENTE G
    Riv Ist Sieroter Ital; 1952; 27(1):1-5. PubMed ID: 14942290
    [No Abstract]   [Full Text] [Related]  

  • 7. [P blood factors in the Vienna population 1951, determined with human natural anti-P serum].
    SPEISER P; WEIGL B
    Klin Med Osterr Z Wiss Prakt Med; 1952 Feb; 7(2):4-61. PubMed ID: 14939523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Research on the distribution of the P factor in the province of Genoa].
    CANEPA G
    Arch Med Interna; 1952; 4(6):223-30. PubMed ID: 13093263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental studies on the P factor by means of natural anti-P heterosera].
    ILLCHMANN-CHRIST A
    Dtsch Z Gesamte Gerichtl Med; 1957; 46(1):46-52. PubMed ID: 13427563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary research on the distribution of the group-specific P factor in the population of Pulgia].
    TANSELLA G
    Riv Ist Sieroter Ital; 1952; 27(4):304-7. PubMed ID: 13004826
    [No Abstract]   [Full Text] [Related]  

  • 11. [Some data on changes in agglutinating properties of the factor P during the process of prolonged blood preservation].
    BAGDASAROV VA
    Probl Gematol Pereliv Krovi; 1961 Dec; 6():49-51. PubMed ID: 13863910
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE APPEARANCE OF THE ERYTHROCYTIC P FACTOR DURING HUMAN ONTOGENESIS].
    RUFFIE J; DUCOS J; MARTY Y; VERGNES H
    C R Hebd Seances Acad Sci; 1964 Feb; 258():2424-5. PubMed ID: 14138909
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfusion hazards; report of a case demonstrating A reaction to the P factor.
    DOCHAT GR
    Ohio State Med J; 1956 Sep; 52(9):940-1. PubMed ID: 13359027
    [No Abstract]   [Full Text] [Related]  

  • 14. [The properdin titer in women with labor pathology or gynecological disease and the role of this titer in the prognosis].
    Malkov JJ
    Zentralbl Gynakol; 1975; 97(17):1047-56. PubMed ID: 1189778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The formation of antibodies against a properdin preparation. II.
    PONDMAN KW; van der HART ; HOOGENDIJK J; van LOGHEM JJ
    Vox Sang; 1960 Feb; 5():142-56. PubMed ID: 14433993
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE BEHAVIOR OF CIRCULATING ANTIBODIES AND PROPERDIN FOLLOWING SENSITIZATION WITH HOMOLOGOUS TISSUE ANTIGENS].
    SCHEIFFARTH F; WARNATZ H; FRENGER W; HALFAR I; TYMPNER KD
    Z Gesamte Exp Med; 1964 Feb; 138():81-91. PubMed ID: 14161934
    [No Abstract]   [Full Text] [Related]  

  • 17. [The "properdin system" and some stomatological diseases. VII. Relation between the serum properdin titer and malignant connective tissue neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():659-61. PubMed ID: 14480070
    [No Abstract]   [Full Text] [Related]  

  • 18. [The "properdin system" and some stomatological diseases. VI. Relation between the serum properdin titer and malignant epithelial neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETTINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():657-9. PubMed ID: 14480071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological studies on the connection between properdin and specific antibodies against deep mycoses].
    STERNBERG TH; McNALL EG
    Dermatol Wochenschr; 1960 Feb; 141():137-44. PubMed ID: 13834489
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contributions to the change in properdin level of the blood serum and to the mechanism of the decrease in titer in connection with renal diseases].
    SZEMERE G; SZABO M; SZEL E
    Kiserl Orvostud; 1962 Sep; 14():340-6. PubMed ID: 13979915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.